摩根中国生物医药混合(QDII)C
(019573)公募QDII
各季度资产配置
| 季报日期 | 净资总值(亿元) | 净资净值(亿元) | 股票 | 债券 | 现金 | 其他 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | |||
| 2026-03-31 | 5.32 | 5.22 | 4.68 | 87.72% | 87.94% | 0.00 | 0.00% | 0.00% | 0.61 | 11.59% | 11.38% | 0.04 | 0.69% | 0.68% |
| 2025-12-31 | 5.20 | 5.11 | 4.50 | 86.39% | 86.62% | 0.00 | 0.00% | 0.00% | 0.68 | 13.28% | 13.05% | 0.02 | 0.33% | 0.33% |
| 2025-09-30 | 6.52 | 6.33 | 5.47 | 83.40% | 83.87% | 0.00 | 0.00% | 0.00% | 0.98 | 15.46% | 15.02% | 0.07 | 1.14% | 1.11% |
| 2025-06-30 | 5.07 | 5.01 | 4.66 | 91.83% | 91.92% | 0.00 | 0.00% | 0.00% | 0.38 | 7.58% | 7.49% | 0.03 | 0.59% | 0.59% |
| 2025-03-31 | 4.73 | 4.68 | 3.97 | 83.78% | 83.94% | 0.00 | 0.00% | 0.00% | 0.74 | 15.85% | 15.69% | 0.02 | 0.37% | 0.37% |
| 2024-12-31 | 4.15 | 4.10 | 3.38 | 81.19% | 81.43% | 0.00 | 0.00% | 0.00% | 0.77 | 18.72% | 18.48% | 0.00 | 0.09% | 0.09% |
| 2024-09-30 | 4.68 | 4.64 | 3.73 | 79.61% | 79.76% | 0.00 | 0.00% | 0.00% | 0.94 | 20.22% | 20.07% | 0.01 | 0.17% | 0.17% |
| 2024-06-30 | 4.38 | 4.33 | 3.24 | 73.70% | 73.98% | 0.00 | 0.00% | 0.00% | 1.02 | 23.57% | 23.32% | 0.12 | 2.73% | 2.70% |
| 2024-03-31 | 4.73 | 4.68 | 3.10 | 65.28% | 65.63% | 0.00 | 0.00% | 0.00% | 1.62 | 34.64% | 34.28% | 0.00 | 0.08% | 0.09% |
| 2023-12-31 | 5.41 | 5.37 | 4.18 | 77.06% | 77.22% | 0.00 | 0.00% | 0.00% | 1.23 | 22.87% | 22.71% | 0.00 | 0.07% | 0.07% |
| 2023-09-30 | 5.69 | 5.65 | 3.32 | 58.05% | 58.34% | 0.00 | 0.00% | 0.00% | 1.28 | 22.65% | 22.49% | 0.00 | 0.08% | 0.08% |